Podiatrists in Gibsonia, PA Accepting Medicare

2 Podiatrists found. Showing 1 - 2

Anthony P Zarra Dpm Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 9010 Audubon Dr, Gibsonia, PA 15044 Phone: 330-758-2775    Fax: 330-758-2787

Larry Campoli, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 5830 Meridian Rd, Gibsonia, PA 15044 Phone: 724-443-7231    Fax: 734-443-4467

News Archive

AAD's National Melanoma/Skin Cancer Screening Program reaches milestone

One person dies from melanoma, the deadliest form of skin cancer, almost every hour. Yet melanoma is often successfully treated, if caught early. That's why thousands of dermatologists across the country offer free skin cancer screenings in their communities through the American Academy of Dermatology's (AAD) National Melanoma/Skin Cancer Screening Program.

Studies examine ability of antiretroviral Maraviroc to control HIV viral loads

According to two studies sponsored by drugmaker Pfizer and published in the New England Journal of Medicine on Wednesday, the antiretroviral drug maraviroc, which is sold as Selzentry by Pfizer, might help control viral loads among HIV-positive people who have shown resistance to other treatments, Reuters reports.

Ranolazine safe but not effective in reducing major cardiac events in ACS patients

The anti-anginal medication ranolazine was shown to be safe in regard to certain outcomes but did not reduce the risk of major cardiovascular events such as death, heart attack or recurrent ischemia following acute coronary syndromes, according to a study in the April 25 issue of JAMA.

Scientists discover new signaling pathway to reduce tumour growth in glioblastoma multiforme

Malignant gliomas are the most common subtype of primary brain tumor - and one of the deadliest. Even as doctors make steady progress treating other types of solid tumor cancers, from breast to prostate, the most aggressive form of malignant glioma, called a glioblastoma multiforme or GBM, has steadfastly defied advances in neurosurgery, radiation therapy and various conventional or novel drugs. But an international team of scientists, headed by researchers at the Ludwig Institute for Cancer Research (LICR) at the University of California, San Diego School of Medicine, reports in the August 15 issue of Genes & Development that they have discovered a new signaling pathway between GBM cells - one that, if ultimately blocked or disrupted, could significantly slow or reduce tumor growth and malignancy.

Read more Medical News

› Verified 4 days ago